| Nov 6 |
Moderna Q3 2024 Preview: Revenue to fall due to continued COVID market share decline
|
| Nov 6 |
Vaccine Stocks Drop on Worries About an RFK Jr. Role
|
| Nov 6 |
Moderna said to shuffle sales leadership; Vertex records first Casgevy sale
|
| Nov 5 |
What's in Store for These 5 Drug & Biotech Stocks in Q3 Earnings?
|
| Nov 5 |
Moderna CEO Bancel steps down as sales chief, Bloomberg News reports
|
| Nov 5 |
Bancel to step down as Moderna chief commercial officer, remain CEO
|
| Nov 5 |
Novavax (NVAX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
|
| Nov 5 |
Carisma Therapeutics to Present New Data on Anti-GPC3 In Vivo CAR-M Therapy for Hepatocellular Carcinoma at SITC 2024
|
| Nov 5 |
Should Moderna Stock Be in Your Portfolio Pre-Q3 Earnings?
|
| Nov 4 |
Moderna (MRNA) Q3 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
|
